Lebrest Letrozole 25 Mg - 5 Box - Hormonal Therapy For Breast Cancer In Postmenopausal Women Ship By Dhl Express

LEBREST Letrozole 2.5 mg – 30 Tablets | Hormonal Therapy for Breast Cancer in Postmenopausal Women

Ship By DHL Express

📝 Product Description

LEBREST Letrozole 2.5 mg is an oral non-steroidal aromatase inhibitor used as hormonal therapy for breast cancer in postmenopausal women. It is primarily indicated for treating hormone receptor-positive early-stage breast cancer, and is also effective in managing advanced or metastatic breast cancer. By lowering estrogen levels in the body, Letrozole helps slow or reverse the growth of estrogen-dependent tumors.

💡 Indications / Benefits / Uses

• Adjuvant therapy in postmenopausal women with hormone receptor-positive early breast cancer

• First-line treatment for postmenopausal women with advanced or metastatic breast cancer

• Extended adjuvant therapy following tamoxifen treatment

• Can be used in cases where cancer has progressed after anti-estrogen therapy

💊 Composition

• Each tablet contains: Letrozole 2.5 mg

📦 Packaging Information

• 1 box contains: 3 blister packs @ 10 tablets

• Total: 30 tablets

🔔 Important Notes

• For use under medical supervision only

• Not for use in premenopausal women

• Store in a cool, dry place away from direct sunlight